Antonio Braga

Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.

R. Berkowitz, L. F. Barbisan, K. Elias, 2016, American journal of obstetrics and gynecology.

Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian cases

R. Berkowitz, N. Horowitz, S. Sun, 2023, Clinics.

Treatment of High-Risk Gestational Trophoblastic Neoplasia.

G. Paiva, Neil S. Horowitz, Antonio Braga, 2024, Hematology/oncology clinics of North America.

Current chemotherapeutic options for the treatment of gestational trophoblastic disease

R. Berkowitz, N. Horowitz, K. Elias, 2022, Expert opinion on pharmacotherapy.

A novel alternative to cytotoxic chemotherapy for gestational trophoblastic disease.

R. Berkowitz, N. Horowitz, K. Elias, 2021, The Lancet. Oncology.

Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease.

R. Berkowitz, N. Horowitz, K. Elias, 2021, Best practice & research. Clinical obstetrics & gynaecology.

Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide

M. Seckl, A. Nogueira-Rodrigues, P. Mora, 2019, World journal of clinical oncology.

Changing Trends in the Clinical Presentation and Management of Complete Hydatidiform Mole Among Brazilian Women

R. Berkowitz, K. Elias, A. Braga, 2016, International Journal of Gynecologic Cancer.